Please login to order a test.
Treatment of susceptible fungal infections, including candidiasis, oral thrush, blastomycosis, histoplasmosis, paracoccidiodomycosis, coccidioidomycosis, chromomycosis, chronic muccotaneous candidiasis, as well as recalcitrant cutaneous dematophytoses.
This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary.
Liquid chromatography/tandem mass spectrometry (LC/MS-MS)
Serum (preferred) or plasma
Transfer separated serum or plasma to a plastic transport tube. Do not use a gel barrier tube. The use of gel-barrier tubes is not recommended due to slow absorption of the drug by the gel. Depending on the specimen volume and storage times, the decrease in drug level due to absorption may be clinically significant.
Causes for Rejection
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|700477||Ketoconazole, Serum/Plasma||10990-0||700478||Ketoconazole, Serum/Plasma||ug/mL||10990-0|